- Global Pharma News & Resources

Global Intravascular Ultrasound Systems (IVUS) Devices Pipeline Market Landscape 2021: Stage of Development, Segment, Territory, Regulatory Path, Estimated Approval Date, Ongoing Clinical Trials -

DUBLIN--(BUSINESS WIRE)--The "Intravascular Ultrasound Systems (IVUS) - Medical Devices Pipeline Product Landscape, 2021" report has been added to's offering.

The report provides comprehensive information about the Intravascular Ultrasound Systems (IVUS) pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Intravascular Ultrasound System is a fiber-optic, catheter-based, near-infrared (NIR) spectroscopy and intravascular ultrasound combined system intended to identify and characterize atherosclerotic plaque in the coronary arteries.


  • Extensive coverage of the Intravascular Ultrasound Systems (IVUS) under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Intravascular Ultrasound Systems (IVUS) and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to Buy

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
  • Identify and understand important and diverse types of Intravascular Ultrasound Systems (IVUS) under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Key Topics Covered:

1 Table of Contents

1.1 List of Tables

1.2 List of Figures

2 Introduction

2.1 Intravascular Ultrasound Systems (IVUS) Overview

3 Products under Development

3.1 Intravascular Ultrasound Systems (IVUS) - Pipeline Products by Stage of Development

3.2 Intravascular Ultrasound Systems (IVUS) - Pipeline Products by Segment

3.3 Intravascular Ultrasound Systems (IVUS) - Pipeline Products by Territory

3.4 Intravascular Ultrasound Systems (IVUS) - Pipeline Products by Regulatory Path

3.5 Intravascular Ultrasound Systems (IVUS) - Pipeline Products by Estimated Approval Date

3.6 Intravascular Ultrasound Systems (IVUS) - Ongoing Clinical Trials

4 Intravascular Ultrasound Systems (IVUS) - Pipeline Products under Development by Companies

4.1 Intravascular Ultrasound Systems (IVUS) Companies - Pipeline Products by Stage of Development

4.2 Intravascular Ultrasound Systems (IVUS) - Pipeline Products by Stage of Development

5 Intravascular Ultrasound Systems (IVUS) Companies and Product Overview

5.1 Arbor Ultrasound Technologies, LLC (Inactive) Company Overview

5.2 Biosense Webster Inc Company Overview

5.3 Boston Scientific Corp Company Overview

5.4 Conavi Medical Inc Company Overview

5.5 Covidien Ltd Company Overview

5.6 Georgia Institute of Technology Company Overview

5.7 Insight Lifetech Co Ltd Company Overview

5.8 Koninklijke Philips NV Company Overview

5.9 Mayo Clinic Company Overview

5.10 North Carolina State University Company Overview

5.11 OCT Medical Imaging Inc Company Overview

5.12 RadioSon Corporation Company Overview

5.13 SIBUS Medical Inc (Inactive) Company Overview

5.14 SoniVie Inc Company Overview

5.15 Soundpipe LLC Company Overview

5.16 Terumo Corp Company Overview

5.17 University of Oxford Company Overview

5.18 University of Texas at Austin Company Overview

6 Intravascular Ultrasound Systems (IVUS)- Recent Developments

6.1 Nov 08, 2021: Boston Scientific Announces Upcoming Conference Schedule

6.2 Nov 04, 2021: Terumo Corp Half Yearly Results For the Period 30 September 2021

6.3 Oct 27, 2021: Boston Scientific Announces Results For Third Quarter 2021

6.4 Sep 09, 2021: Boston Scientific Announces 2021 Investor Day Meeting

6.5 Aug 17, 2021: NanoVibronix Announces Results of Annual Meeting of Stockholders Held

6.6 Aug 04, 2021: Terumo Revises its Full-Year Financial Guidance for FY2021

6.7 Aug 04, 2021: Terumo Corp. Announces Consolidated Financial Results for the First Quarter Ended June 30, 2021

6.8 Jun 24, 2021: Peter Arduini named CEO of GE healthcare

6.9 Jun 03, 2021: GE Healthcare and the American College of Cardiology join forces to advance AI in cardiac care

6.10 May 24, 2021: Boston Scientific to Participate in Bernstein's 37th Annual Strategic Decisions Conference

6.11 Mar 22, 2021: Terumo and Allied Telesis jointly develop a smooth operating environment for infusion systems

6.12 Feb 17, 2021: Medtronic Executives to Speak at Upcoming Investor Conferences

6.13 Feb 16, 2021: Medtronic to Announce Financial Results for Its Third Quarter of Fiscal Year 2021

6.14 Feb 12, 2021: Boston Scientific Announces February and March 2021 Conference Schedule

6.15 Feb 04, 2021: Terumo announce Financial Statements

6.16 Feb 04, 2021: Terumo Announces Change of Directors and Executive Officers

7 Appendix

For more information about this report visit

Laura Wood, Senior Press Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Editor Details

  • Company:
    • Businesswire
Last Updated: 12-May-2022